Skip to main navigation
Seer Logo
Seer Logo
  • Overview
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • News & Events
    • News Releases
    • Investor Calendar
    • Presentations
  • Financials
    • SEC Filings
    • Quarterly Results
  • Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Scientific & Clinical Advisors
  • Resources
    • Investor FAQ
    • Email Alerts
    • Contact IR
  • News Releases

June 7, 2023
Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center
June 1, 2023
Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies
May 9, 2023
Seer Reports First Quarter 2023 Financial Results
April 20, 2023
Seer to Report First Quarter 2023 Financial Results on May 9, 2023
March 29, 2023
Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression
March 2, 2023
Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook
February 21, 2023
Seer to Present at the Cowen 43rd Annual Health Care Conference
February 9, 2023
Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
printed-materials icon
email icon
rss icon
Seer Logo

Seer.bio

  • Technology & Products
  • Events
  • Library
  • Careers
  • About Us

Investor Relations

  • Stock Information
  • News & Events
  • Financial Information
  • Corporate Governance
  • Investor Resources
  • LinkedIn
  • Twitter
© 2023 Seer, Inc. All rights reserved.
(English) This icon serves as a link to download the eSSENTIAL Accessibility assistive technology app for individuals with physical disabilities. It is featured as part of our commitment to diversity and inclusion.